Trials / Completed
CompletedNCT03757065
Cell Surface Marker Expression in Autoimmune Diseases
A Cross-Sectional Study of Cell Surface Marker Expression in Participants With Autoimmune or Inflammatory Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- Alpine Immune Sciences, Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to explore the expression of cell-surface markers in the following seven disease areas: (a) systemic lupus erythematosus, (b) Sjogren's syndrome, (c) multiple sclerosis, (d) systemic sclerosis, (e) Crohn's disease, (f) ulcerative colitis and (g) inflammatory myositis.
Conditions
- Systemic Lupus Erythematosus
- Sjogren's Syndrome
- Multiple Sclerosis
- Systemic Sclerosis
- Crohn's Disease
- Ulcerative Colitis
- Inflammatory Myositis
Timeline
- Start date
- 2019-06-12
- Primary completion
- 2019-10-25
- Completion
- 2019-10-25
- First posted
- 2018-11-28
- Last updated
- 2020-08-27
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT03757065. Inclusion in this directory is not an endorsement.